REG - Genus - Director/PDMR Shareholding
11/09/2025 12:30
For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250911:nRSK0015Za&default-theme=true
RNS Number : 0015Z Genus PLC 11 September 2025
11 September 2025
Genus plc
Director/PDMR Shareholding
Genus plc (LSE: GNS) announces that on 10 September 2025, conditional share
awards were granted under the Genus 2019 Performance Share Plan ('PSP') over
ordinary shares in Genus to the Executive Directors and members of the Genus
Executive Leadership Team ('GELT') as listed in table A below. In addition,
following Genus's compulsory deferral requirements relating to the annual
bonus earned by Executive Directors and GELT for the financial year ended 30
June 2025, share awards were granted over ordinary shares under the Genus 2019
Deferred Share Bonus Plan ('DSBP') as listed in table B below.
Details of the performance conditions that apply to the conditional share
awards can be found in the Directors' Remuneration Report of the Genus 2025
Annual Report which will be published next month.
The price at which PSP and DSBP share awards have been granted was determined
in accordance with the PSP and DSBP rules.
Genus further announces that:
· in accordance with the terms of joining contained in his employment
contract, Andy Russell, Chief Financial Officer, was granted contingent rights
over 9,014 ordinary shares in Genus under an individual award agreement with a
normal vesting date of 10 September 2027;
· in accordance with the terms of joining contained in her employment
contract, Lucie Grant, Group General Counsel and Company Secretary was granted
contingent rights over 1,351 ordinary shares in Genus under an individual
award agreement with a normal vesting date of 17 March 2027;
· Matt Culbertson, Chief Operating Officer PIC, was granted contingent
rights over 12,610 ordinary shares in Genus under an individual award
agreement with a normal vesting date of 10 September 2028; and
· Jim Low, Chief Operating Officer ABS, was granted contingent rights
over 12,610 ordinary shares in Genus under an individual award agreement with
a normal vesting date of 10 September 2028,
as listed in table C below.
Subject to the terms of the individual award agreements and continued service,
the awards will vest on the normal vesting dates as specified above.
No consideration was paid for the grant of these awards and no consideration
is due in connection with the vesting of these awards.
The below notifications, made in accordance with Article 19 of the Market
Abuse Regulation (EU) 596/2014 as it forms part of domestic law by virtue of
the European Union (Withdrawal) Act 2018, give further detail of the nil-cost
option awards made on 10 September 2025.
For further information please contact:
Genus:
Vaughn Walton, Deputy Company
Secretary
Tel: +44 (0)1256 347100
Table A - GELT 2019 Performance Share Plan Options
1. Details of the person discharging managerial responsibilities / person closely
associated
a. Name 1. Jorgen Kokke
2. Andy Russell
3. Mark Birri
4. Matt Culbertson
5. Jim Low
6. Elena Rice
7. Angelle Rosata
8. Lucie Grant
2. Reason for the notification
a. Position/status 1. Chief Executive Officer
2. Chief Financial Officer
3. Chief Corporate Development Officer
4. Chief Operating Officer Genus PIC
5. Chief Operating Officer Genus ABS
6. Chief Scientific Officer
7. Group Human Resources Director
8. Group General Counsel & Company Secretary
b. Initial notification Initial notification
/Amendment
3. Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a. Name Genus plc
b. LEI 54930022EOITNKSIGH56
4. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a. Description of the Ordinary shares of 10p each.
Financial instrument, type of instrument
Identification code
GB0002074580
b. Nature of the transaction Award of shares granted under the PSP over ordinary shares in Genus.
c. Price(s) and volume(s) Numbers 1 to 8 in the left-hand column correspond to the relevant PDMR as
detailed in boxes 1a and 2a above.
Price(s) Volume(s)
1. 0p 32,573
2. 0p 21,369
3. 0p 8,102
4. 0p 13,559
5. 0p 12,131
6. 0p 11,880
7. 0p 10,764
8. 0p 10,801
d. Aggregated information
· Aggregated volume
· Price n/a
e. Date of the transaction 2025-09-10
f. Place of the transaction Outside a trading venue.
d.
Aggregated information
· Aggregated volume
· Price
n/a
e.
Date of the transaction
2025-09-10
f.
Place of the transaction
Outside a trading venue.
Table B - GELT 2019 Deferred Share Bonus Plan Options
1. Details of the person discharging managerial responsibilities / person closely
associated
a. Name 1. Jorgen Kokke
2. Mark Birri
3. Matt Culbertson
4. Jim Low
5. Elena Rice
6. Angelle Rosata
7. Lucie Grant
2. Reason for the notification
a. Position/status 1. Chief Executive Officer
2. Chief Corporate Development Officer
3. Chief Operating Officer Genus PIC
4. Chief Operating Officer Genus ABS
5. Chief Scientific Officer
6. Group Human Resources Director
7. Group General Counsel & Company Secretary
b. Initial notification Initial notification
/Amendment
3. Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a. Name Genus plc
b. LEI 54930022EOITNKSIGH56
4. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a. Description of the Ordinary shares of 10p each.
Financial instrument, type of instrument
Identification code
GB0002074580
b. Nature of the transaction Award of shares granted under the DSBP following the compulsory deferral of
33% and 25% of annual bonus for Executive Directors and members of GELT
respectively in respect of bonuses earned in the financial year ended 30 June
2025.
c. Price(s) and volume(s) Numbers 1 to 7 in the left-hand column correspond to the relevant PDMR as
detailed in boxes 1a and 2a above.
Price(s) Volume(s)
1. 0p 15,491
2. 0p 613
3. 0p 3,224
4. 0p 2,862
5. 0p 2,803
6. 0p 2,474
7. 0p 710
d. Aggregated information
· Aggregated volume
· Price n/a
e. Date of the transaction 2025-09-10
f. Place of the transaction Outside a trading venue.
d.
Aggregated information
· Aggregated volume
· Price
n/a
e.
Date of the transaction
2025-09-10
f.
Place of the transaction
Outside a trading venue.
Table C - Restricted Stock Awards
1. Details of the person discharging managerial responsibilities / person closely
associated
a) Name 1. Andy Russell
2. Lucie Grant
3. Matt Culbertson
4. Jim Low
2. Reason for the notification
a) Position/status 1. Chief Financial Officer
2. Group General Counsel and Company Secretary
3. Chief Operating Officer Genus PIC
4. Chief Operating Officer Genus ABS
b) Initial notification Initial notification
/Amendment
3. Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Genus plc
b) LEI 54930022EOITNKSIGH56
4. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the Ordinary shares of 10p each.
Financial instrument, type of instrument
Identification code
GB0002074580
b) Nature of the transaction Grant of contingent rights over ordinary shares in Genus under individual
award agreements
c) Price(s) and volume(s) Numbers 1 to 4 in the left-hand column correspond to the relevant PDMR as
detailed in boxes 1a and 2a above.
Price(s) Volume(s)
1. 0p 9,014
2. 0p 1,351
3. 0p 12,610
4. 0p 12,610
5. Aggregated information
· Aggregated volume
· Price n/a
6. Date of the transaction 2025-09-10
7. Place of the transaction Outside a trading venue.
5.
Aggregated information
· Aggregated volume
· Price
n/a
6.
Date of the transaction
2025-09-10
7.
Place of the transaction
Outside a trading venue.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHUAAARVBUKAARRecent news on Genus
See all newsREG - Stock Exch Notice - Admission to Trading - 12/09/2025
AnnouncementREG - Official List - Official List Notice
AnnouncementREG - Genus - Director/PDMR Shareholding
AnnouncementREG - Genus - Additional Listing
AnnouncementREG - Genus - Accelerated Chinese porcine JV formation
Announcement